Cholinesterase inhibitory activity of two farnesylacetone derivatives from the Brown Alga Sargassum sagamianum

Archives of Pharmacal Research

Volumn 26, Issue 10, 2003, Pages 796-799

  Ryu, Geonseek ^a   Soo, Hee Park ^a   Eun, Sook Kim ^a   Byoung, Wook Choi ^a   Shi, Yong Ryu ^b   Bong, Ho Lee ^a  

^a Hanbat National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Cholinesterase inhibitory activity; Farnesylacetone derivatives; Marine brown algae; Sragassum sagamianum

Indexed keywords

6,10,14 TRIMETHYLPENTADECA 5,10 DIEN 2,12 DIONE; 6,10,14 TRIMETHYLPENTADECA 5,9,13 TRIEN 2,12 DIONE; 6,10,14-TRIMETHYLPENTADECA-5,10-DIEN-2,12-DIONE; 6,10,14-TRIMETHYLPENTADECA-5,9,13-TRIEN-2,12-DIONE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; FARNESYLACETONE; KETONE; TERPENE;

ARTICLE; BROWN ALGA; CHEMISTRY; COMPARATIVE STUDY; ISOLATION AND PURIFICATION; ISOMERISM; SARGASSUM;

ALGAE, BROWN; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ISOMERISM; KETONES; SARGASSUM; TERPENES;

EID: 30444453995     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980022     Document Type: Article

References (25)

1. Bates R. B., Gale D. M., and Gruner B. J., The stereoisomeric farnesol. J. Org. Chem., 28, 1086-1089 (1963).
2. Bazelyansky M., Robey E., and Kirsch J. F., Fraction diffusion limited component of reactions catalyzed by acetylcholinesterase. Biochem. , 25, 125-130 (1986).
3. Berkman C. E., Quinn D. A., and Thompson C.M., International of acetylcholinesterase with the enantiomers of malaoxon and isomalathion. Chem. Res. Toxicol., 6, 724-730 (1993).
4. Brzostowska M., He X., Greig N. H., Rapoport S. I., and Brossi A., Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-physovenol: selective inhibitors of acetyl and, or butyrylcholinesterase. Med. Chem. Res., 2(4), 238-246 (1992).
5. Ellman G. L., Courtney D. K., Andres, V., and Featherstone R. M., A new and rapid colotimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88-95 (1961).
6. Gregson R. P., Kazlauskas R., Murphy P. T., and Wells R. J., New metabolites from the brown alga Cystophora torulosa. Aust. J. Chem., 30, 2527-2532 (1977).
7. Greig N. H., Utsuki T., Yu Q., Zhu X., Holloway H.W., Perry T., Lee B., Ingram D. K., and Lahiri D. K., Butyrylcholinesterase: a new therapeutic target in AD treatment? Alzheimer Insights, 7(2), 1-6 (2001a).
8. Greig N. H., Utsuki T., Yu Q., Zhu X., Holloway H.W., Perry T., Lee B., Ingram D. K., and Lahiri D. K., A new therapeutic target in Alzheimers disease treatment: attention to butyroylcholinesterase. Curr. Med. Res. Opinion, 17(2), 1-6 (2001b).
9. Greig N. H., Pei X. F., Soncrant T. T., Ingram D. K., and Brossi A., Phenserine and ring C hetero-analogs: Drug candidates for the treatment of Alzheimer's disease. Med. Res. Reviews, 15(1), 3-31 (1995c).
10. Huegin, W., Potentiating action of tacrine on the effects of succinylcholine. Anaesthesist, 11, 338-340 (1962).
11. Ibata, K., Mizuno, M., Takigawa, T., and Tanaka, Y., Long-chain betula prenol-type polyprenol from the Ginkgo biloba. Biochem. J., 213, 305-311 (1983).
12. Ishitsuka, M., Kusumi, T., Nomura, Y., Konno, T., and Kakisawa, H., New geranylgeranylbenzoquinone derivatives from Sargassum tortile. Chem. Lett., 1269-1272 (1979).
13. Kazlauskas, R., King, L., Murphy, P. T., Warren, R. G., and Wells, R. J., New metabolites from the brown algal genus Cystophora. Aust . J. Chem., 34, 439-447 (1981).
14. Kikuchi, T., Yokoi, T., Nakazawa, S., Kuroda, H., Masada, Y., Kitamura, K., and Kuriyama, K., Structure and absolute configuration of sargatriol, a new isopreoid chromenol from a brown alga Sargassum tortile C. Agardh. Chem. Pharm. Bull., 31(1), 106-113 (1983).
15. Kusumi T., Ishitsuka M., Nomura Y., Konno T., and Kakisawa H., New farnesylacetone derivatives from Sargassum micracanthum. Chem. Lett., 1181-1184 (1979a).
16. Kusumi, T., Shibata, Y., Ishitsuka, M., and Kinoshita, T., Structure of new plastoquinones from the brown alga Sargassum serratifolium. Chem. Lett., 277-278 (1979b).
17. Kusumi, T., Ishitsuka, M., Nomura, Y., Konno, T., and Kakisawa, H., New farnesylacetone derivatives from Sargassum microcanthum. Chem. Lett., 1181-1184 (1979c).
18. Liu, J. S., Zhu, Y. L., Yu, C. M., Zhou, Y. Z., Han, Y. Y., Wu, F. W., and Qi, B. F., The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can. J. Chem., 64(4), 837-839 (1986).
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J, Protein measurement wih the Folin phenol Reagent. J. Biol. Chem., 193, 265-275 (1951).
20. Romani, R., Antognelli, C., Baldracchini, F., Santis, A. D, Isani, G., Giovannini E., and Rosi G., Increased acetylcholinesterase activities in specimens of Sparus auratus exposed to sublethal Copper concentrations. Chemico-Biological Interactions, 145(3), 321-329 (2003).
21. Ryu, G., Park, S. H., Kim, E. S., Choi, B. W., and Lee, B. H., Potent Butyrylcholinesterase (BuChE) Inhibitory Activity of Two Plastoquinone Derivatives from the Brown Alga Sargassum sagamianum (in preparation).
22. Segawa, M. and Shirahama, H., New plastoquinones from the brown alga Sargassum sagamianum var. Yezoense. Chem. Lett., 1365-1366 (1987).
23. Shizuri, Y., Matsukawa, S., Ojika, M., and Yamada, K., Two new farnesylacetone derivatives from the brown alga Sargassum micracathum. Phytochem., 21(7), 1808-1809 (1982).
24. Tanaka, Y., Sato, H., and Kageyu, A., Carbon-13 NMR analysis of polystyrene by means of model compounds. Polymer, 23, 1087-1090 (1982).
25. Yu, Q. S., Holloway, H. W., Utsuki , T., Brossi, A., and Greig, N. H., Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease. J. Med. Chem., 42(10), 1855-1861 (1999).